Picture of Medios AG logo

ILM1 Medios AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-10.32%
3m-6.98%
6m-12.89%
1yr-30.81%
Volume Change (%)
10d/3m-62.65%
Price vs... (%)
52w High-26.98%
50d MA-5.2%
200d MA-8.02%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)10.07
PEG Ratio (f)0.42
EPS Growth (f)31.8%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.73
Price to Tang. Book1.89
Price to Free Cashflow22.57
Price to Sales0.19
EV to EBITDA5.5

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.13%
Return on Equity4.1%
Operating Margin1.76%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m516.8626.541,357.411,610.781,784.71,948.82,080.8240.34%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+124.71-40.51+88.66+0.13+20.39+38.99+19.97n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Medios AG EPS forecast chart

Profile Summary

Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 1st, 1999
Public Since
January 1st, 1999
No. of Employees
515
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
de flag iconDusseldorf Stock Exchange
Shares in Issue
23,805,723
Blurred out image of a map
Address
Heidestrasse 9, BERLIN, 10557
Web
https://medios.ag/
Phone
+49 30232566800
Contact
Claudia Nickolaus
Auditors
Baker Tilly Gmbh & Co. KG

ILM1 Share Price Performance

Upcoming Events for ILM1

Q1 2024 Medios AG Earnings Release

Medios AG Annual Shareholders Meeting

Q2 2024 Medios AG Earnings Release

Similar to ILM1

Picture of Cannovum Cannabis AG logo

Cannovum Cannabis AG

de flag iconDusseldorf Stock Exchange

Picture of SynBiotic SE logo

SynBiotic SE

de flag iconDusseldorf Stock Exchange

Picture of Viromed Medical AG logo

Viromed Medical AG

de flag iconDusseldorf Stock Exchange

FAQ